IMPROVEMENT IN THE ERYTHROPOIESIS OF CHRONIC HAEMODIALYSIS PATIENTS WITH DESFERRIOXAMINE

This publication has 10 references indexed in Scilit:

• Serum Aluminum Levels and Erythrocyte Dihydropteridine Reductase Activity in Patients on Hemodialysis
  New England Journal of Medicine, 1987
• NON‐TRANSFERRIN PLASMA IRON
  British Journal of Haematology, 1987
• Treatment of Hemodialysis-Related Porphyria Cutanea Tarda with Deferoxamine
  New England Journal of Medicine, 1987
• Interpretation of Serum Aluminum Values in Dialysis Patients
  American Journal of Clinical Pathology, 1986
• COPPER CHELATION AND THE NEURO-OPHTHALMIC TOXICITY OF DESFERRIOXAMINE
  The Lancet, 1986
• The iron-chelating agent picolinic acid enhances transferrin receptors expression in human erythroleukaemic cell lines
  British Journal of Haematology, 1985
• Anemia of end-stage renal disease (ESRD)
  Kidney International, 1985
• Serum ferritin as a guide for iron stores in chronic hemodialysis patients
  Kidney International, 1984
• ALUMINIUM POISONING: DIALYSIS ENCEPHALOPATHY, OSTEOMALACIA, AND ANAEMIA
  The Lancet, 1983
• Evaluation of Iron Status in Patients on Chronic Hemodialysis: Relative Usefulness of Bone Marrow Hemosiderin, Serum Ferritin, Transferrin Saturation, Mean Corpuscular Volume and Red Cell Protoporphyrin
  Nephron, 1983